Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYNJ2 | O15056 | 2/20 | 0.60 |
| ▸ | BACE1 | P56817 | 6/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.57 |
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | APEX1 | P27695 | 5/20 | 0.57 |
| ▸ | RECQL | P46063 | 5/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.57 |
| ▸ | SNCA | P37840 | 4/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.57 |
| ▸ | HPGD | P15428 | 4/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | RAD52 | P43351 | 2/20 | 0.57 |
| ▸ | CNR1 | P21554 | 1/20 | 0.57 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.47 |
| ▸ | ELAVL3 | Q14576 | 1/20 | 0.46 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30933022 | 0.91 | PTGS1 (0.61) | SYNJ2BACE1KDM4EMAPTAPEX1 | |
| SCHEMBL347773 | 0.90 | SYNJ2 (0.59) | SYNJ2BACE1KDM4EMAPTAPEX1 | |
| SCHEMBL17938778 | 0.90 | SYNJ2 (0.59) | SYNJ2BACE1KDM4EMAPTAPEX1 | |
| SCHEMBL30538696 | 0.88 | BACE1 (0.60) | SYNJ2BACE1KDM4EMAPTAPEX1 | |
| SCHEMBL350730 | 0.87 | KDM1A (0.51) | SYNJ2BACE1KDM4EMAPTAPEX1 | |
| SCHEMBL17938831 | 0.85 | SYNJ2 (0.49) | SYNJ2BACE1KDM4EMAPTAPEX1 | |
| SCHEMBL30217486 | 0.85 | SYNJ2 (0.49) | SYNJ2BACE1KDM4EMAPTAPEX1 | |
| SCHEMBL14700129 | 0.82 | BACE1 (0.57) | SYNJ2BACE1KDM4EMAPTAPEX1 | |
| SCHEMBL17534890 | 0.81 | BACE1 (0.59) | SYNJ2BACE1KDM4EMAPTAPEX1 | |
| SCHEMBL17548765 | 0.81 | BACE1 (0.59) | SYNJ2BACE1KDM4EMAPTAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | claimed |
| US-12630450-B1 | Somatic embryonic cell suspension for wastewater treatment | King Faisal University (SA) | 2026-05-19 | — | — | US | disclosed |
| CN-122055354-A | Lipid compounds and related compositions and uses | 波西达治疗公司 | 2026-05-15 | — | — | CN | disclosed |
| WO-2025049925-A2 | LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES | POSEIDA THERAPEUTICS, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | disclosed |
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240355451-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | NESTLE SA (CH) | 2024-10-24 | — | — | US | disclosed |
| EP-4391834-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | Société des Produits Nestlé S.A. (CH) | 2024-07-03 | — | — | EP | disclosed |
| WO-2024107938-A2 | POLYPHENOL LIPID NANOPARTICLES AND METHODS OF USE | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-05-23 | — | — | WO | disclosed |
| CN-117813017-A | Method for improving intestinal microbiota diversity | 雀巢产品有限公司 | 2024-04-02 | — | — | CN | disclosed |
| US-20240101791-A1 | POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-03-28 | — | — | US | disclosed |
| WO-2024059282-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2023025722-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | Société des Produits Nestlé S.A. (CH) | 2023-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630450-B1 | Somatic embryonic cell suspension for wastewater treatment | ALPG, PROX1, KIT | SYNJ2 2621/4885BACE1 1865/4885KDM4E 542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.